Measuring cannabis use among young Canadians before and after legalization

Measuring cannabis use among young Canadians before and after legalization

image

A new survey of cannabis users in Canada shows that legalization lowered usage rates among some and increased for others.

Despite concerns that cannabis legalization in Canada would cause an increase in cannabis use, a new study says rates of use among high-risk young adults showed an overall decrease in the first few years of legalization. Those who reported never using cannabis before legalization didn’t show significant increases after legalization. 

Many who reported high rates of cannabis use prior to legalization reported consuming less in the years after legalization. In contrast, some who initially reported using cannabis infrequently prior to legalization increased their use post-legalization. 

The new study from researchers in Canada and the US looked at rates of reported cannabis use among high-risk young adults in Ontario, Canada, aged 19.5 to 23 years.

More than 600 participants who satisfied specific criteria for substance use were surveyed every four months for the three years between February 2017 and February 2020, with three surveys conducted pre-legalization and after legalization. The data was analyzed from March to May 2023.

Of those surveyed, people who reported using cannabis frequently prior to cannabis being legalized showed significant reductions in use and consequences over time. The report notes that this likely reflects an “aging out pattern” for younger users who use cannabis less as they get older. It also highlights no significant negative outcomes regarding cannabis use or associated harms within the group connected to legalization.

While some use increased and some use decreased following legalization, “occasional use” was the most commonly reported category before legalization and “no use” was the most commonly reported category after legalization. 

The “occasional cannabis use” category showed the most change. Only 83 of the 207 who reported occasional use prior to legalization reported the same following legalization. Another 66 of those switched to reporting no use, while 47 increased to “regular use.”

Despite this relatively positive news, the study also cautions that some participants did exhibit notable increases in the frequency of cannabis use, and that the majority of those who reported frequent use of cannabis prior to legalization reported no decrease following legalization, noting that “the determinants of escalation and persistence of high-frequency cannabis use in young adults warrants further examination.”

The study also highlights that cannabis use pre-legalization in Canada was fairly normalized, meaning that legalization itself may have had little impact on public perception of any potential risks. 

More than half (346) of those surveyed identified as female, while 273 identified as male. The mean age was just over 21, with about half holding a bachelor’s degree or higher.

Related Articles

420 with CNW — Major Hitch: DeSantis Dislikes Cannabis, But Major Funder Is Working for End of Prohibition

420 with CNW — Major Hitch: DeSantis Dislikes Cannabis, But Major Funder Is Working for End of Prohibition

image

Florida governor Ron DeSantis has been vocal about his disapproval of recreational marijuana, calling it a significant issue and expressing his concerns about its impact. However, an interesting twist arises as the driving force behind DeSantis’ presidential campaign, led by GOP strategist Jeff Roe through Vanguard Field Strategies and Axiom Strategies, is actively supporting a campaign to legalize recreational marijuana in Florida.

Axiom and Vanguard have received nearly $29 million from Smart and Safe Florida, an organization advocating for a 2024 ballot initiative to legalize adult-use cannabis. Ironically, the companies, despite their involvement in advancing marijuana legalization in Florida, are simultaneously working to secure DeSantis’ presidential election, albeit on an antimarijuana platform. They have received more than $25 million from the pro-DeSantis super PAC, Never Back Down, which plays a pivotal role in the DeSantis campaign, handling various campaign activities and events as well as the governor’s transportation.

This poses a challenge for DeSantis, as legal restrictions prevent coordination between the campaign and super PAC, forcing him to rely on a group whose goals sometimes clash with his own. Recent tensions have emerged between Never Back Down and the DeSantis campaign, particularly concerning strategy and timing in the primary race.

In one incident, DeSantis’ allies were frustrated when the super PAC posted a strategy memo on Axiom’s website, setting expectations for the governor’s debate performance. Additionally, a leaked recording from a Never Back Down donor briefing suggested a tight timeline for DeSantis to surpass former President Donald Trump, which some Republicans found arbitrary.

The conflict over marijuana use further complicates DeSantis’ image as being tough on recreational drugs, potentially putting him at odds with his constituents. He has expressed concerns about the potency of marijuana and its possible contamination with substances such as fentanyl.

Axiom’s diverse client portfolio has occasionally led to situations where the company works for clients with conflicting ideologies. Its involvement with the procannabis initiative began in 2022, months before it joined forces with Never Back Down.

The initiative to legalize recreational cannabis is funded mainly by Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a major player in the cannabis sector, and could be a major issue for Florida Democrats to revive their status in the state. Smart and Safe Florida has gathered enough signatures to potentially qualify for the ballot.

However, it’s uncertain whether the initiative will make it to the ballot, as Attorney General Ashley Moody, a DeSantis ally, has urged the state Supreme Court to strike it down, claiming it misleads voters.

Moreover, DeSantis has remained steadfast in his opposition to recreational use, signing legislation to tighten advertising restrictions and expressing concerns about its impact on the workforce and prosperity.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Police in Quebec seize tens of thousands of plants,  2.5 tons dried cannabis in series of raids

Police in Quebec seize tens of thousands of plants, 2.5 tons dried cannabis in series of raids

Sûreté du Québec’s Contraband Investigations Division has seized tens of thousands of cannabis plants and a large quantity of dried cannabis and cannabis products, as well as millions in cash in a series of raids this year.

Eight arrests were announced on September 27 in connection with the cases, with three other arrests expected. 

The seizures and arrests are the result of multiple searches that so far have yielded 56,650 cannabis plants, nearly 2.5 tonnes of bulk cannabis, ready for sale, 131 grams of hashish and 10 kg of edible cannabis products. 

Police also seized more than $275,000 in cash, production equipment with a value of more than $2.5 million, along with six properties as criminal property, valued at more than $2.5 million. 

Police say the investigation “sheds light” on what they call a structured cannabis production network that uses registration certificates “granted by Health Canada to give an appearance of legitimacy to their large-scale distribution and trafficking activities.” (translated). 

Sûreté du Québec operated through the province’s ACCES Cannabis program that targets both indoor and outdoor cannabis producers. 

On September 15, Sûreté du Québec, along with the RCMP, announced it had dismantled several outdoor production sites for illegal cannabis.  Arrests were also made in connection with these operations, and others were said to be expected.

These seizures are in addition to other seizures that began as early as June of this year. Local media accompanied at least one raid of an outdoor farm earlier this month

These seizures of plants will be added to the provisional results of the operations which began last June. During this season, thousands of illegal cannabis plants were seized throughout Quebec, tickets relating to the Cannabis Control Act were issued, and arrests were made under the Cannabis Act.

In an unrelated case, a sergeant with Sûreté du Québec is currently under investigation relating to alleged perjury in a case where the sergeant appears to have misled the court about efforts to verify an ACMPR authorization for cannabis for medical purposes.

Images via soreltracy.com

Related Articles

Quebec police officer under investigation following alleged perjury in medical cannabis case

Quebec police officer under investigation following alleged perjury in medical cannabis case

A sergeant with the Sûreté du Québec is currently under criminal investigation related to alleged false statements she made while investigating a medical production licence. 

As covered recently in Le Journal de Montreal, Sergeant Dany Lafleur was found by a court in 2020 to have allegedly misled the court about her contacting Health Canada to determine the validity of a Health Canada document authorizing cannabis possession for medical purposes. She is now subject to a criminal investigation following a civil suit filed against her and her colleagues earlier this year by Christian Lanthier, who provided the Health Canada document.

Court records show that the document was presented to law enforcement by Lanthier during the execution of a search warrant at a residence in Repentigny, Quebec, related to a fraud investigation with an associate of the Hells Angels. 

While searching the residence, officers say they smelled cannabis and then later discovered cannabis inside a vehicle they were searching under the original warrant. Lanthier presented the document to officers, telling them he was authorized to possess up to 150 grams of cannabis based on a 30-gram-a-day allowance.

Ultimately, the document made its way to the officer responsible for evidence, Dany Lafleur, who, along with other police officers, say they suspected the document was not legitimate. Court records also document that police ultimately secured a second search warrant to search the residence for drugs prior to learning of the authorizing document.

Lafleur told the court she had called Health Canada’s helpline—one set up for these types of requests from law enforcement—but did not hear back. She argued that this led her to conclude the document was invalid. 

There are also conflicting statements from several officers regarding how the document was discovered and by whom.

The court initially ruled that the search was a valid one because the document was not valid. In a follow-up ruling in November 2020, the court found that Lafleur had likely misled the court about contacting Health Canada to determine the document’s validity. 

This was partly supported by a lack of evidence showing that the Sergeant had contacted Health Canada at the time she claims. 

This was also supported by looking at the helpdesk registry maintained by Health Canada, which was presented as evidence, along with call records from Lafleur’s personal and professional numbers. 

No evidence was found of a call made by Lafleur to Health Canada’s call line on the day of the search or to a number beginning with the same area code as the assistance line. Lafleur’s first call recorded in the Health Canada register was made a month after the search.

The court also found that the officers who determined the Health Canada authorization was false had limited drug investigation experience and were unaware of medical cannabis regulations or the document type they were provided. 

The court also disputed officers’ claims of how the document was discovered. 

Translated from the court ruling: “The Court must therefore conclude that these police officers were not candid and transparent when they participated in preparing the telewarrant request, and when they testified before the Court, on points directly affecting the legality of the authorization requested and executed. Furthermore, when it comes to the verification call to Health Canada on the day of the search, the Tribunal can only think that an attempt was made to mislead it.”

Lanthier filed his civil suit in June of this year, leading police to consult with the Director of Criminal and Penal Prosecutions (DPCP) to determine whether there were grounds for an investigation into the actions of Lafleur.

The document in question was a Document for the Access to Cannabis for Medical Purposes Regulations, signed by Dr. Lawrence Fremont of Markham, Ontario, prescribing Lanthier the use of 30 grams of cannabis per day. According to Linkedin, Fremont operates a hair loss recovery centre.


Enthea Announces Nationwide Availability of Ketamine Treatment to Employees

Massachusetts-based healthcare provider Enthea has revealed that it is now offering psychedelic-assisted therapy coverage in employee healthcare plans nationwide. The provider was in the news last year when soap company Dr. Bronners announced that it would be offering psychedelic-assisted therapy coverage to its employees via Enthea. Around 7% of Dr. Bronners’ employees signed up for the psychedelics benefit package, and the company says those employees experienced “dramatic improvements” in their mental health.

Nonprofit healthcare Enthea will now extend the coverage to patients across the entire United States as ancillary benefits in employee healthcare plans. Enthea focuses on ketamine-assisted therapy and considers itself the nation’s “first and only” provider of psychedelic-assisted therapy coverage.

Enthea cofounder and CEO Sherry Rais said extending psychedelic coverage nationwide is a significant step for the company as it strives to help employees deal with the mental challenges associated with the workplace. She noted that Enthea’s services would make it easier for businesses to embrace psychedelic-based treatments for their employees and said the company was proud to offer a “safe and effective” treatment option with the potential to benefit the millions of Americans currently living with mental-health issues.

Psychedelics are a relatively new entrant into the psychiatric industry, but they are already predicted to revolutionize mental-health treatments in a major way. Several studies have found that psychedelics have the potential to treat a myriad of conditions with minimal side effects and at relatively low doses. The ability to treat conditions such as post-traumatic stress disorder (PTSD), anxiety, eating disorders and depression with barely any adverse side effects and without the need for daily doses makes psychedelics an attractive alternative to conventional mental-health treatments.

With the body of research connecting psychedelics to significant and long-term improvements in mental health, lawmakers in several states have begun working on legislation to legalize the therapeutic use of psychedelics. Three states, including California, have decriminalized psychedelics, and there has even been a push for employers to provide coverage for psychedelic-assisted therapy.

Dr. Bronners was among the first companies to offer this coverage, and more companies will likely include psychedelic coverage in their employee healthcare packages. According to Enthea, partnerships with institutions such as Innerwell and Skylight Psychedelics allowed it to expand its network of providers.

Innerwell CEO Lisa Kennedy said it is critical for employers to invest in their employees’ mental health, adding that her team comprised trained clinicians who would use data-driven approaches to deliver compassionate care to patients.

Ketamine isn’t the only psychedelic that can be used for therapeutic purposes. If all goes according to plan, many enterprises that are running other psychedelic drug-development programs, such as atai Life Sciences N.V. (NASDAQ: ATAI), could see their products obtain FDA approval and added onto healthcare insurance plans by employers in years to come.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN

EnWave signs commercial lease agreement with pet treat company to accelerate new product development

(Globe Newswire) Delta, B.C. — EnWave Corporation announced today that it has signed a commercial lease agreement with a major pet treat company in the United States. The partner previously signed a commercial royalty-bearing license with EnWave and pursuant to the Agreement, EnWave will lease a new 10kW Radiant Energy Vacuum (REV) dehydration machine for the partner to use for the development and test marketing of new, innovative pet treat products.

Prior to signing the agreement, the partner and EnWave conducted preliminary product development at the company’s innovation center located in Delta, British Columbia. The product concepts were received favourably by the partner, compelling both parties to continue exploration of material commercial product opportunities using REV technology in the pet treat space.

EnWave intends to grant certain product exclusivities to the partner if the next phase of product development and market testing is successful, and pursuant to partner’s acquisition of large-scale REV dehydration machinery.

Advertisement

TILT Holdings appoints Tim Conder as permanent CEO, announces change of board chairperson

(Globe Newswire) Phoenix — TILT Holdings Inc., a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that Interim chief executive officer Tim Conder will transition to permanent CEO, effective as of today.

Mr. Conder has been a member of TILT’s board of directors since October 2019, served as the company’s president and chief operating officer from July 2019 until November 2020, and has served as Interim CEO since April 2023.

The company also announced Art Smuck has been appointed chair of the board, succeeding John Barravecchia, who will continue to serve as board member and chair of the audit committee. Mr. Smuck brings extensive experience with large cannabis brands and complex distribution operations to his new role.

“Tim has been instrumental in bringing financial discipline to TILT, and since being appointed Interim CEO, we believe he has already made significant headway in strengthening the company’s operations and financial position,” said TILT board chair, Art Smuck. “This includes implementing cost-cutting measures across the organization and making strategic shifts to the company’s business model and approach to brand partnerships. The board has every confidence in Tim’s leadership and ability to continue executing the Company’s refined business strategy and build a foundation for profitable growth in 2024 and beyond.”

Advertisement

Mr. Conder brings 15 years of experience operating innovative, high-performing teams in the technology, logistics and supply-chain sectors. Prior to TILT, Mr. Conder co-founded Blackbird Logistics, a technology and logistics provider in the cannabis space, in 2015, and most recently served as the president of the Blackbird business unit and chief technology officer at HERBL, Inc., a distributor and supply chain provider for cannabis.

“I am excited to continue leading TILT on a permanent basis and have been impressed with the team’s commitment to our strategic goals and refined plan,” said Tim Conder, CEO of TILT. “I look forward to working more closely with the board and leveraging my experience both within and outside of the cannabis sector to return TILT to growth and profitability as we seek to drive value creation for all of our stakeholders.”